If you have been reading about peptidase and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-04-04. Numbers and descriptions here follow the published literature rather than marketing material.
Purity assessment relies mainly on reverse-phase high-performance liquid chromatography with ultraviolet detection. Because the peptide lacks a strong chromophore, detection often uses backbone absorbance near 214 nm. Identity is confirmed by mass spectrometry, typically electrospray ionization or matrix-assisted laser desorption, comparing the measured mass against the expected value. Amino acid analysis can verify composition after acid hydrolysis. Diastereomer content and residual counterions are reported less often, although both can influence biological assays.
Lyophilized material is generally stable for extended periods when kept dry at or below minus twenty degrees Celsius. Working solutions are less stable, and common practice is to aliquot and freeze them so that repeated freeze-thaw cycles are avoided. Aqueous solutions are sensitive to pH extremes and to microbial growth, so short-term storage at refrigerator temperature is typical. Oxidation and hydrolysis are the principal degradation routes. Reconstitution with sterile water or a mild buffer is standard, and solutions should be protected from light.
Regulatory treatment varies by jurisdiction. In Russia the compound is a registered prescription product, while in the European Union and the United States it is generally handled as a research chemical without a marketing authorization. Suppliers therefore operate outside pharmaceutical oversight, and buyers rely on supplier documentation for purity and identity claims. Chain of custody and third-party testing are the main verification tools. Analysts note that the absence of a pharmacopoeial monograph for research-grade material limits standardization across vendors.
Proposed mechanisms centre on the GABAergic system. Animal and tissue studies report changes in GABA-A receptor expression and reduced activity of GABA transaminase, the enzyme that degrades GABA. Effects on monoamine turnover, including serotonin and dopamine pathways, are also described, and a separate line of work links the peptide to increased expression of brain-derived neurotrophic factor in hippocampal tissue. Most of these findings come from rodent models and cell preparations. How the individual observations combine into a single coherent mode of action is not settled.
Pharmacokinetic data are sparse and largely derived from animal work. After intranasal administration the peptide appears in plasma within minutes, and reported half-lives are short, on the order of minutes to tens of minutes. Degradation proceeds through ordinary proteolytic cleavage into constituent amino acids and smaller fragments. Direct evidence that intact Selank reaches brain tissue in meaningful amounts is limited, and the extent of blood-brain barrier penetration is debated. Some authors argue that fragments, not the parent peptide, carry much of the observed activity.
| Property | Value | Notes |
|---|---|---|
| Typical purity report | 95% or higher by HPLC | Area percentage at 214 nm |
| Identity confirmation | Mass spectrometry | Electrospray or MALDI |
| Powder storage | -20 C, desiccated | Protect from light |
| Solution storage | 2-8 C short term | Freeze aliquots for longer |
| Quality document | Certificate of analysis | States method and value |
Animal studies have examined behaviour in tests of anxiety, memory retention and stress response, and several report changes in neurotrophic or neurotransmitter-related markers. The human evidence base is much smaller, consisting mainly of short trials conducted in Russia with limited reporting in English-language journals. Sample sizes are modest and outcome measures vary between studies, so the findings are best described as preliminary. Independent replication under modern trial standards has not been widely reported.
Outside its country of origin the compound is generally handled as a research chemical rather than an approved medicine. No regulatory approval from the United States Food and Drug Administration or the European Medicines Agency has been granted for human use. Identity and purity are normally checked by reverse-phase high-performance liquid chromatography, with mass spectrometry used to confirm the molecular mass. Lyophilised material is stored cold and desiccated, and repeated freeze-thaw cycles are avoided.
Selank is a synthetic heptapeptide developed in Russia as a structural analogue of tuftsin, a naturally occurring immunomodulatory tetrapeptide. Its sequence, Thr-Lys-Pro-Arg-Pro-Gly-Pro, keeps the tuftsin core at the N-terminus and appends a Pro-Gly-Pro tail. Researchers at the Institute of Molecular Genetics in Moscow synthesized the compound during the 1990s while searching for peptides with combined anxiolytic and immunomodulatory activity. The added tail was intended to resist enzymatic cleavage and prolong the molecule's presence in circulation.
The compound has a calculated molecular weight near 751.9 daltons and carries a net positive charge at physiological pH because of its arginine residue. It dissolves freely in water and in common aqueous buffers, and typically appears as a white or off-white lyophilized powder. The amide backbone makes the molecule susceptible to peptidases, which limits oral use and favors intranasal or parenteral routes. Nomenclature in the literature varies: the substance is also described by the sequence abbreviation TP-7 and by a Russian trade designation.
Regulatory status differs sharply by region. Selank holds a Russian marketing authorization, where it is supplied mainly as nasal drops, while authorities elsewhere have not approved it for medical use. Material sold internationally is therefore usually labeled as a research chemical rather than a medicine. Peer-reviewed publications come predominantly from Russian laboratories, and sample sizes are generally small. Whether the compound produces comparable effects under independent, well-controlled replication remains an open question that the broader literature has not settled.
Dry powder is normally held at -20 degrees Celsius or lower, in a sealed container with desiccant and protection from light. Reconstituted solutions are usually kept at 2 to 8 degrees Celsius for short periods and frozen for longer ones. Proline residues at several positions are generally associated with some resistance to peptidase attack, but chemical stability still declines at neutral to alkaline pH and at elevated temperature. Exact shelf-life figures are product-specific and are not standardised across suppliers.
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography, with mass spectrometry used to confirm molecular mass and sequence information. Amino acid analysis and peptide mapping may supplement these methods. Certified reference standards are scarce, and many commercial lots are sold as research chemicals without a pharmacopoeial monograph. Regulatory treatment differs by country: Selank is a registered prescription medicine in Russia, while in the European Union and the United States it is not an approved drug and may fall under research-chemical or unapproved-product frameworks.
Selank is a hydrophilic peptide and dissolves readily in water and in aqueous buffers. The lyophilised powder is typically a white to off-white solid. Because short peptides are prone to hydrolysis and oxidation, handling benefits from limiting exposure to heat, moisture and strong light. Working solutions are commonly prepared in sterile water or saline, and repeated freeze-thaw cycles are avoided to reduce aggregation and loss of activity. These practices reflect general laboratory convention rather than published stability specifications.
== Beginnings of Genentech == A young Swanson now found himself unemployed. Swanson was interviewing almost daily, attempting to find a job. However, he was still fascinated by the potential of recombinant DNA technology, and decided to cold call scientists working on the technology, with the hope that one of them would be interested in commercializing it. One of the scientists he contacted, Herbert Boyer, expressed interest but was hesitant of meeting up with Swanson at first. Boyer was an academic scientist, and was not well versed on the matters of business. Swanson convinced Boyer to meet, for a short time, at his University of California, San Francisco lab. The short meeting was extended to three hours, and Boyer came out determined to commercialize the technology he had helped pioneer. He would deal with the science behind the product, whereas Swanson would work on obtaining funds, and managing the organization as a whole. The two agreed to form a partnership, and each put down $500 to cover legal fees. Swanson made the decision to pursue the creation of the company full-time, rather than obtain a job at an established institution or company. He explains his logic in an interview: "(I told myself) "Look, I think this is important. If I don't do this, I'm not going to like myself so much for not having given it a shot." So that was what made that decision." Swanson then set out to identify their first marketable product, and quickly focused on the human protein insulin.
Due to the mutiny of the Military Police of Espírito Santo State in which the agents demanded the correction of the remuneration for inflation, along with retroactive payments, criminal gangs and drug traffickers took advantage of the situation and a crime wave of violence, carjacking and looting spread across Espírito Santo, with most public services and businesses being closed. The Espírito Santo state government called in assistance from the National Public Security Force and the Brazilian Armed Forces to restore law and order in Vitória and other cities until military policemen began to return to their duties after two weeks of strike action. By 25 February, all military policemen in Espírito Santo had ended their strikes. At least 215 people were killed in the violence.
== Biosynthesis == Gramicidin S biosynthetic pathway consists of two-enzyme of nonribosomal peptide synthases (NRPSs), gramicidin S synthetase I (GrsA) and gramicidin S synthetase II (GrsB), to give a product as a cyclic decapeptide. Within the biosynthetic pathway, there are total of five modules that specifically recognize, activate, and condense the amino acids to gramicidin S. Starting module GrsA consists of three domains: Adenylation (A) domain where it incorporates the amino acid and activates it by adenylation using ATP, Thiolation (T) domain or peptidyl carrier protein (PCP) in which the adenylated amino acid gets covalently attached to the 4´-phosphopantetheine group and this gets loaded onto the conserved serine in the T domain, Epimerization (E) domain where it epimerizes L-amino acid to D-amino acid. Starting module GrsA loads D-Phe onto the system. Second enzyme cluster GrsB contains four modules, each containing condensation (C), adenylation (A), and thiolation (T) domains and thioesterase domain (TE) at the end. C domain forms a peptide bond between two amino acids, D-Phe and L-Pro. L-Val, L-Orn, and L-Leu are incorporated sequentially by the next three modules of GrsB. After repeating the whole module synthesis once again, TE domain cyclizes and releases the two peptides and dimerize them together to form the final product.
Sources: en.wikipedia.org
The World Health Organization (WHO) recommends two doses of vaccine for all children. In countries with a high risk of disease the first dose should be given around nine months of age. Otherwise it can be given at twelve months of age. The second dose should be given at least one month after the first dose. This is often done at age 15 to 18 months. After one dose at the age of nine months 85% are immune, while a dose at twelve months results in 95% immunity. In the United States, the Centers for Disease Control and Prevention (CDC) recommends that children aged six to eleven months traveling outside the United States receive their first dose of MMR vaccine before departure and then receive two more doses; one at 12–15 months (12 months for children in high-risk areas) and the second as early as four weeks later. Otherwise the first dose is typically given at 12–15 months and the second at 4–6 years. In the UK, the National Health Service (NHS) recommendation is for a first dose at around 13 months of age and the second at three years and four months old. Health Canada recommends that children traveling outside North America should receive an MMR vaccine if they are aged six to 12 months. However, after the child is 12 months old they should receive two additional doses to ensure long-lasting protection.
== External links == A Detailed Glycolysis Animation provided by IUBMB (Adobe Flash Required) The Glycolytic enzymes in Glycolysis at RCSB PDB Glycolytic cycle with animations at wdv.com Metabolism, Cellular Respiration and Photosynthesis – The Virtual Library of Biochemistry, Molecular Biology and Cell Biology The chemical logic behind glycolysis at ufp.pt Expasy biochemical pathways poster Archived 2010-06-20 at the Wayback Machine at ExPASy MedicalMnemonics.com: 317 5468 metpath: Interactive representation of glycolysis Archived 2015-04-02 at the Wayback Machine
After World War I, these cumulatively resulted in the highly restrictive Emergency Quota Act of 1921 and the Immigration Act of 1924. Over the first two decades of the 21st century, the Republican Party adopted an increasingly nativist platform, advocating against sanctuary cities and in favour of building a wall with Mexico and reducing the number of immigrants permitted to settle in the country. Ultimately, the Trump administration furthered many of these policy goals, including the adoption of harsh policies such as the Remain in Mexico and family separation policies vis-à-vis refugees and migrants arriving from Central America via Mexico. Islamophobic policies such as the travel ban targeted primarily at Muslim-majority countries also feature prominently in attempts to create a hostile environment for immigrants perceived by populists as not belonging to the predominant WASP culture in the United States. India's citizenship registration policy serves to create a hostile environment for the country's Muslim community in the regions in which it has been implemented. The Indian government is presently in the process of building several detention camps throughout India in order to detain people not listed on the register. On 9 January 2019, the Union government released a '2019 Model Detention Manual', which said that every city or district, having a major immigration check post, must have a detention centre. The guidelines suggest detention centres with 3 metres (9 feet 10 inches) high boundary walls covered with barbed wires.
phenotype The composite of the observable morphological, physiological, and behavioral traits of an organism that result from the expression of the organism's genotype as well as the influence of environmental factors and the interactions between the two.
Sources: en.wikipedia.org
== Occurrence == Seeds and phytopharmaceuticals derived from the plant Ginkgo biloba are dietary supplements used to improve memory, brain metabolism, and blood flow, and to treat neuronal disorders. It has been long used for a wide range of medicinal purposes. For instance, in Japan and China, Ginkgo biloba is used to treat cough, bronchial asthma, irritable bladder and alcohol use disorder. Ginkgotoxin is found in the seeds and, in lesser amounts, in the leaves of Ginkgo biloba. The seeds can be consumed as is and the leaves can be used to prepare the dietary supplements. Analyses of raw seeds from eight different locations in Japan by high-performance liquid chromatography showed concentrations of ginkgotoxin varying from 0.173 to 0.4 mg/g of seeds. Also, there is a seasonal variation of ginkgotoxin concentration in the seeds. The maximum has been observed in August. Analyses of the powder of Ginkgo biloba capsules revealed the presence of ginkgotoxin. However, as most oral supplements are made from the leaves, which contain only small amounts of ginkgotoxin, below the level of toxicological relevance. Ginkgotoxin-5'-glucoside is a derivative of ginkgotoxin that possesses a glycosyl in the 5' position. Its content is higher than the concentration of ginkgotoxin in heated seeds (boiled or roasted). Liberation of ginkgotoxin by enzymatic hydrolysis of the glycosidic linkage is possible. Nevertheless, the toxicity or the mechanism of action of the glucoside form is not fully understood. Ginkgotoxin can also be found in plants of the genus Albizia.
The outer "skin" of the lichen, the cortex, is composed of closely packed fungal hyphae and serves to protect the thallus from water loss due to evaporation as well as harmful effects of high levels of irradiation. In X. parietina, the thickness of the thalli is known to vary depending on the habitat in which it grows. Thalli are much thinner in shady locations than in those exposed to full sunshine; this has the effect of protecting the algae that cannot tolerate high light intensities. The ascospores made by X. parietina are hyaline (colorless and translucent), ellipsoid, and typically measure 13–16 by 7–9 μm. Like all Teloschistaceae lichens, they are polarilocular, meaning they are divided into two components (locules) separated by a central septum with a perforation. This septum ranges from 3 to 8 μm wide.
== Research == In his academic research, Verdine made fundamental discoveries about how organisms manage their genomes: how they tag specific cell types and conduct search-and-destroy operations for cancer-causing abnormalities. Verdine has published more than 190 academic articles. In 2005, Verdine and Anirban Banerjee published research in crystallography showing how enzymes could be used to fix flawed DNA. In 2013, Verdine received a research grant to study cell-penetrating miniproteins in order to target cancer cells. His work has led to the FDA approval of the drugs romidepsin and paritaprevir. Verdine is also the inventor of stapled peptide technology, which stabilizes peptides intended for therapeutic use by introducing an all-hydrocarbon “staple” into the peptide’s linear backbone. These “stapled” peptides have a higher affinity for their targets, enter cells more easily and are less readily degraded.
Sources: en.wikipedia.org
Purity is usually reported as an HPLC area percentage, most often measured at 214 nm. Identity is confirmed separately by mass spectrometry. A certificate of analysis should state both the method and the observed value.
Dry powder is kept frozen, desiccated, and shielded from light. Dissolved material is aliquoted and frozen to limit freeze-thaw cycles. Short-term refrigerated storage is common for working solutions.
Russia registers it as a prescription nasal product. Most other markets classify it as a research chemical with no approved medical use. Oversight of purity and labeling is consequently minimal in those markets.
Reports describe modulation of GABA signalling, changes in monoamine turnover and effects on neurotrophic factor expression. These observations come mainly from animal and cell studies. A single unifying mechanism has not been demonstrated.